Search - tctmd.com

Displaying 781 - 800 of 1450

Sort: Relevancy | Date

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

News Industry News

Latest Data Shows OrbusNeich’s COMBO™ Dual Therapy Stent has Excellent Healing Benefits

September 18, 2014

News Conference News TCT 2014

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

September 17, 2014

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

News Industry News

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

September 16, 2014

News Industry News

New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

September 16, 2014

News Industry News

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

News Conference News TCT 2014

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

September 15, 2014

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

News Industry News

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

September 15, 2014

News Industry News

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

September 15, 2014

News Industry News

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

September 15, 2014

News Conference News TCT 2014

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

September 15, 2014

News Industry News

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

Advertisement

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

Latest Data Shows OrbusNeich’s COMBO™ Dual Therapy Stent has Excellent Healing Benefits

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

Keynote Address Focuses on Newer DES, Problematic Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content